156 related articles for article (PubMed ID: 29097782)
1. Disease-relevant signalling-pathways in head and neck cancer: Taspase1's proteolytic activity fine-tunes TFIIA function.
Gribko A; Hahlbrock A; Strieth S; Becker S; Hagemann J; Deichelbohrer M; Hildebrandt A; Habtemichael N; Wünsch D
Sci Rep; 2017 Nov; 7(1):14937. PubMed ID: 29097782
[TBL] [Abstract][Full Text] [Related]
2. Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription.
Takeda S; Sasagawa S; Oyama T; Searleman AC; Westergard TD; Cheng EH; Hsieh JJ
J Clin Invest; 2015 Mar; 125(3):1203-14. PubMed ID: 25664857
[TBL] [Abstract][Full Text] [Related]
3. Taspase1 processing alters TFIIA cofactor properties in the regulation of TFIID.
Malecová B; Caputo VS; Lee DF; Hsieh JJ; Oelgeschläger T
Transcription; 2015; 6(2):21-32. PubMed ID: 25996597
[TBL] [Abstract][Full Text] [Related]
4. TFIIA transcriptional activity is controlled by a 'cleave-and-run' Exportin-1/Taspase 1-switch.
Schrenk C; Fetz V; Vallet C; Heiselmayer C; Schröder E; Hensel A; Hahlbrock A; Wünsch D; Goesswein D; Bier C; Habtemichael N; Schneider G; Stauber RH; Knauer SK
J Mol Cell Biol; 2018 Feb; 10(1):33-47. PubMed ID: 28992066
[TBL] [Abstract][Full Text] [Related]
5. The importin-alpha/nucleophosmin switch controls taspase1 protease function.
Bier C; Knauer SK; Docter D; Schneider G; Krämer OH; Stauber RH
Traffic; 2011 Jun; 12(6):703-14. PubMed ID: 21418451
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the catalytically impaired Taspase1 T234V or Taspase1 D233A variants does not have a dominant negative effect in T(4;11) leukemia cells.
Bier C; Hecht R; Kunst L; Scheiding S; Wünsch D; Goesswein D; Schneider G; Krämer OH; Knauer SK; Stauber RH
PLoS One; 2012; 7(5):e34142. PubMed ID: 22570686
[TBL] [Abstract][Full Text] [Related]
7. TBP-like protein (TLP) interferes with Taspase1-mediated processing of TFIIA and represses TATA box gene expression.
Suzuki H; Isogai M; Maeda R; Ura K; Tamura TA
Nucleic Acids Res; 2015 Jul; 43(13):6285-98. PubMed ID: 26038314
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of TFIIA by Taspase1 activates TRF2-specified mammalian male germ cell programs.
Oyama T; Sasagawa S; Takeda S; Hess RA; Lieberman PM; Cheng EH; Hsieh JJ
Dev Cell; 2013 Oct; 27(2):188-200. PubMed ID: 24176642
[TBL] [Abstract][Full Text] [Related]
9. Uncleaved TFIIA is a substrate for taspase 1 and active in transcription.
Zhou H; Spicuglia S; Hsieh JJ; Mitsiou DJ; Høiby T; Veenstra GJ; Korsmeyer SJ; Stunnenberg HG
Mol Cell Biol; 2006 Apr; 26(7):2728-35. PubMed ID: 16537915
[TBL] [Abstract][Full Text] [Related]
10. A facelift for the general transcription factor TFIIA.
Høiby T; Zhou H; Mitsiou DJ; Stunnenberg HG
Biochim Biophys Acta; 2007; 1769(7-8):429-36. PubMed ID: 17560669
[TBL] [Abstract][Full Text] [Related]
11. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
12. Taspase1: a 'misunderstood' protease with translational cancer relevance.
Wünsch D; Hahlbrock A; Jung S; Schirmeister T; van den Boom J; Schilling O; Knauer SK; Stauber RH
Oncogene; 2016 Jun; 35(26):3351-64. PubMed ID: 26657154
[TBL] [Abstract][Full Text] [Related]
13. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
14. Bioassays to monitor Taspase1 function for the identification of pharmacogenetic inhibitors.
Knauer SK; Fetz V; Rabenstein J; Friedl S; Hofmann B; Sabiani S; Schröder E; Kunst L; Proschak E; Thines E; Kindler T; Schneider G; Marschalek R; Stauber RH; Bier C
PLoS One; 2011; 6(5):e18253. PubMed ID: 21647428
[TBL] [Abstract][Full Text] [Related]
15. AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2.
Deng P; Wang J; Zhang X; Wu X; Ji N; Li J; Zhou M; Jiang L; Zeng X; Chen Q
Carcinogenesis; 2018 Jul; 39(7):937-947. PubMed ID: 29741610
[TBL] [Abstract][Full Text] [Related]
16. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S
Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-2 and -14 in p16-positive and -negative HNSCC after exposure To 5-FU and docetaxel In Vitro.
Aderhold C; Umbreit C; Faber A; Birk R; Sommer JU; Hörmann K; Schultz JD
Anticancer Res; 2014 Sep; 34(9):4929-37. PubMed ID: 25202075
[TBL] [Abstract][Full Text] [Related]
18. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
19. Allosteric inhibition of Taspase1's pathobiological activity by enforced dimerization in vivo.
Bier C; Knauer SK; Wünsch D; Kunst L; Scheiding S; Kaiser M; Ottmann C; Krämer OH; Stauber RH
FASEB J; 2012 Aug; 26(8):3421-9. PubMed ID: 22623586
[TBL] [Abstract][Full Text] [Related]
20. Expression of Genes Encoding Cell Motility Proteins during Progression of Head and Neck Squamous Cell Carcinoma.
Kakurina GV; Kondakova IV; Spirina LV; Kolegova ES; Shashova EE; Cheremisina OV; Novikov VA; Choinzonov EL
Bull Exp Biol Med; 2018 Dec; 166(2):250-252. PubMed ID: 30488206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
